Lv1
30 积分 2022-08-29 加入
Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety
7天前
已完结
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma
7天前
已完结
Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection
7天前
已完结
Novel Treatment Options for Multiple Myeloma
7天前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
22天前
已完结
A Rare Case of Daratumumab-Associated Encephalopathy in Multiple Myeloma
24天前
已关闭
Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients
1个月前
已完结
Toxicités ophtalmologiques des nouveaux traitements anticancéreux
1个月前
已完结
Characteristics and utilization of the three BCMA-targeted therapies in multiple myeloma
1个月前
已完结
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
1个月前
已完结
皖公网安备34019202002308
